These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19106302)

  • 1. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
    Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
    Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
    J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of glycogen synthase kinase (GSK)-3alpha and GSK-3beta in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells.
    Cho J; Rameshwar P; Sadoshima J
    J Biol Chem; 2009 Dec; 284(52):36647-36658. PubMed ID: 19858210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload.
    Maejima Y; Galeotti J; Molkentin JD; Sadoshima J; Zhai P
    Am J Physiol Heart Circ Physiol; 2012 Oct; 303(8):H979-88. PubMed ID: 22904158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
    Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
    Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms.
    Liu R; Wang L; Chen C; Liu Y; Zhou P; Wang Y; Wang X; Turnbull J; Minassian BA; Liu Y; Zheng P
    Mol Cell Biol; 2008 Dec; 28(23):7236-44. PubMed ID: 18824542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
    Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
    Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
    Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
    Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
    Chen B; Pan H; Zhu L; Deng Y; Pollard JW
    Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.
    Piazza F; Manni S; Tubi LQ; Montini B; Pavan L; Colpo A; Gnoato M; Cabrelle A; Adami F; Zambello R; Trentin L; Gurrieri C; Semenzato G
    BMC Cancer; 2010 Oct; 10():526. PubMed ID: 20920357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
    Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
    J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
    Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSK-3alpha directly regulates beta-adrenergic signaling and the response of the heart to hemodynamic stress in mice.
    Zhou J; Lal H; Chen X; Shang X; Song J; Li Y; Kerkela R; Doble BW; MacAulay K; DeCaul M; Koch WJ; Farber J; Woodgett J; Gao E; Force T
    J Clin Invest; 2010 Jul; 120(7):2280-91. PubMed ID: 20516643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
    Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.
    Hardt SE; Sadoshima J
    Circ Res; 2002 May; 90(10):1055-63. PubMed ID: 12039794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.